Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionMontag A & Associates Inc
Latest Disclosed Ownership3,471 shares
Latest Disclosed Value $ 483,704
Montag A & Associates Inc reports 9.50% increase in ownership of GILD / Gilead Sciences, Inc.

On April 29, 2026 - Montag A & Associates Inc filed a 13F-HR form disclosing ownership of 3,471 shares of Gilead Sciences, Inc. (CH:GILD) valued at $483,704 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 3,170 shares of Gilead Sciences, Inc.. This represents a change in shares of 9.50% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F GILEAD SCIENCES COM 375558103 3,471 301 9.50 484 24.16 0.0225
2026-02-02 2025-12-31 13F GILEAD SCIENCES COM 375558103 3,170 -9 -0.28 389 10.51 0.0178
2025-11-12 2025-09-30 13F GILEAD SCIENCES COM 375558103 3,179 637 25.06 353 25.27 0.0162
2025-08-07 2025-06-30 13F GILEAD SCIENCES COM 375558103 2,542 142 5.92 282 4.85 0.0137
2025-05-05 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,400 0 0.00 269 21.27 0.0135
2025-01-30 2024-12-31 13F GILEAD SCIENCES COM 375558103 2,400 0 0.00 222 9.95 0.0105
2024-11-05 2024-09-30 13F GILEAD SCIENCES COM 375558103 2,400 0 0.00 201 22.56 0.0095
2024-07-31 2024-06-30 13F GILEAD SCIENCES COM 375558103 2,400 0 0.00 165 -6.29 0.0083
2024-05-07 2024-03-31 13F GILEAD SCIENCES COM 375558103 2,400 -245 -9.26 176 -18.22 0.0088
2024-02-07 2023-12-31 13F GILEAD SCIENCES COM 375558103 2,645 0 0.00 214 8.08 0.0119
2023-11-09 2023-09-30 13F GILEAD SCIENCES COM 375558103 2,645 0 0.00 198 -2.46 0.0125
2023-08-09 2023-06-30 13F GILEAD SCIENCES COM 375558103 2,645 0 0.00 204 -7.31 0.0126
2023-05-11 2023-03-31 13F GILEAD SCIENCES COM 375558103 2,645 -125 -4.51 219 -7.59 0.0143
2023-02-02 2022-12-31 13F GILEAD SCIENCES COM 375558103 2,770 800 40.61 238 94.26 0.0159
2022-11-09 2022-09-30 13F GILEAD SCIENCES COM 375558103 1,970 1,000 103.09 122 103.33 0.0084
2022-08-10 2022-06-30 13F GILEAD SCIENCES COM 375558103 970 0 0.00 60 3.45 0.0039
2022-05-02 2022-03-31 13F GILEAD SCIENCES COM 375558103 970 0 0.00 58 -17.14 0.0031
2022-02-09 2021-12-31 13F GILEAD SCIENCES COM 375558103 970 0 0.00 70 2.94 0.0035
2021-11-08 2021-09-30 13F GILEAD SCIENCES COM 375558103 970 0 0.00 68 1.49 0.0037
2021-08-03 2021-06-30 13F GILEAD SCIENCES COM 375558103 970 0 0.00 67 6.35 0.0036
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 970 0 0.00 63 10.53 0.0035
2021-02-12 2020-12-31 13F GILEAD SCIENCES COM 375558103 970 970 57 0.0035
2020-11-12 2020-09-30 13F GILEAD SCIENCES COM 375558103 0 -8,899 -100.00 0 -100.00
2020-08-04 2020-06-30 13F GILEAD SCIENCES COM 375558103 8,899 724 8.86 685 12.11 0.0599
2020-05-06 2020-03-31 13F GILEAD SCIENCES COM 375558103 8,175 8,175 611 0.0610
2019-08-06 2019-06-30 13F GILEAD SCIENCES COM 375558103 0 -3,299 -100.00 0 -100.00
2019-05-01 2019-03-31 13F GILEAD SCIENCES COM 375558103 3,299 -550 -14.29 214 -11.20 0.0198
2019-02-06 2018-12-31 13F GILEAD SCIENCES COM 375558103 3,849 -6,030 -61.04 241 -68.41 0.0259
2018-11-07 2018-09-30 13F GILEAD SCIENCES COM 375558103 9,879 -26,679 -72.98 763 -70.54 0.0668
2018-08-08 2018-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 36,558 -3,328 -8.34 2,590 -13.87 0.2659
2018-08-01 2018-06-30 13F GILEAD SCIENCES COM 375558103 36,558 -3,328 2,590
2018-05-07 2018-03-31 13F GILEAD SCIENCES COM 375558103 39,886 -20,233 -33.65 3,007 -30.18 0.3096
2018-02-09 2017-12-31 13F GILEAD SCIENCES COM 375558103 60,119 11,036 22.48 4,307 8.30 0.4165
2017-11-06 2017-09-30 13F GILEAD SCIENCES COM 375558103 49,083 49,083 3,977 0.4269
2015-08-17 2015-06-30 13F GILEAD SCIENCES COM 375558103 0 -14,375 -100.00 0 -100.00
2015-05-12 2015-03-31 13F GILEAD SCIENCES COM 375558103 14,375 14,375 1,411 0.2041
2015-02-04 2014-12-31 13F GILEAD SCIENCES COM 375558103 0 -20,095 -100.00 0 -100.00
2014-11-04 2014-09-30 13F GILEAD SCIENCES COM 375558103 20,095 -32,532 -61.82 2,139 -50.97 0.3528
2014-08-06 2014-06-30 13F GILEAD SCIENCES COM 375558103 52,627 52,627 4,363 0.7113
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.